{
    "code": "02025053",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025053",
    "time": "2019-02-15 03:53:27",
    "許可證字號": "衛署藥輸字第025053號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/07\/14",
    "發證日期": "98\/07\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202505302",
    "中文品名": "易莎平注射劑",
    "英文品名": "IXEMPRA for Injection",
    "適應症": "IXEMPRA合併capecitabine適用於治療對anthracycline和taxane治療有抗藥性，或對taxane有抗藥性又不能接受進一步anthracycline治療的轉移性或局部晚期乳癌患者。",
    "劑型": "243凍晶注射劑",
    "包裝": "15毫克小瓶 附8毫升\/小瓶裝溶劑 45毫克小瓶 附23.5毫升\/小瓶裝溶劑 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "IXABEPILONE"
    ],
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470008500  BAXTER ONCOLOGY GMBH",
        "製造廠廠址": "KANTSTR. 2, 33790 HALLE\/WESTFALEN, GERMANY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F250034000  Corden Pharma Latina S.p.A.",
            "製造廠廠址": "VIA DEL MURILLO KM. 2800, 04013 SERMONETA, LATINA, ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1000000200",
            "成分名稱": "IXABEPILONE",
            "含量描述": "",
            "含量": "16.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1000000200",
            "成分名稱": "IXABEPILONE",
            "含量描述": "",
            "含量": "47.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "長*寬*高 : 65 X 55 X 70 mm",
        "特殊劑型": "",
        "顏色": "白色至灰白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Ixempra Inj 15mg Spec-04-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025053&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PIL-106-08-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025053&Seq=006&Type=9"
        },
        {
            "title": "Carton-106-08-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025053&Seq=005&Type=8"
        },
        {
            "title": "15mg Label-106-08-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025053&Seq=004&Type=8"
        },
        {
            "title": "8ml Label-106-08-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025053&Seq=003&Type=8"
        }
    ]
}